The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Just under 2% of shares traded today with £2M more buys than sales yet £50M wiped off the MCAP. What a load of ******.
Gutted about the update but good to see them being proactive with the data and findings. Still not concerned and looking forward to all the other irons being developed this year.
And still thing the LFT will make Us good money in the near term.
Foxo
After taking some time to take in the new proposed approach by the Gov which I have to admit didn’t look good at first sight for Avacta being involved but still have the EU etc.
If you were to unveil a new testing plan etc now it would not push the masses towards the vaccine releasing the news how they have has woken everyone up to the thought of “if I am fully vaccinated I will again be free” now timing is everything I believe whilst all the work goes on in the background to stockpile U.K. tests etc. The vaccine rollout will have had an almighty final push to protect as many as possible, then unleash the best in the world test so we can gain control of this disease.
Just my thoughts, added more yesterday and still full of confidence for this company.
Hi all,
I posted some time ago about NHS workers using a saliva test for routine testing it turns out this is a LAMP test that is then processed off site to test all hospital staff, all staff are required to not eat or drink anything before conducting the test, once the test is conducted it is sent for analysis which again underlined how difficult these tests are to control, for use in general public the saliva test will simply not be sufficient due to the requirement of not having consumed anything before conducting the test.
Also this gives a huge amount of credit to Avacta for the change in direction and producing the best in class LFT for the world stage whilst promoting the power of the IP it solely owns. NCYT although a great result for them cannot and will not exceed Avactas achievement and usability of the test.
Ignore the idiots what we have is truly outstanding and I fully expect the company to make a hell of a lot of money in the near term and be the key to getting many economies back on track.
Foxo
Having a fookin nightmare this morning trying to transfer my shares from trading account to my new ISA, shares sold ok (as thought they would) but can’t buy back into my ISA now left it with Halifax traders, not a happy man at the minute
Good morning all,
Can see this beauty starting to build nicely from this morning, should imagine that drop today was to mop up a load of stop losses set at the £2 mark before bouncing back, this would allow the MM to gather a raft of shares on the cheap.
Really exciting times ahead, like others I think the news will drop on Monday next week in line with Bojo’s big national press announcement and future plan. Was a little worried for a minute as the drop looked similar to the placing drop but a re-read of the information and quick watch of the interviews set me right.
Massive potential here to revolutionise the medical world and upgrade from the antibody market which dominates the globe.
Ignore the morons, hold of you believe and top up on the gifts that are presented, lots of shares trading hands and wouldn’t be surprised to get a TR1 soon also.
GL all, enjoy the sunshine!
Hello all,
Been one hell of a weekend and can’t wait for the coming days/weeks/months, thought I would add to the 75M tests per week article, if all tests were from our marvellous tech then a 3 month supply at £2 per test profit would hit £1.8 BILLION, does not include Europe/Asia/US or BAMS or Cancer play, the sheer scope of this is staggering, try to get some sleep :-)
Just out of interest I wonder how many of you guys would take a vaccine if available, I am firmly in the no camp but wanted to get a feel from the group, will post yes and no posts recommend which one. I am not doing this for recommends but the way just curious :-)